NYMC > News and Events > NYMC in the News

This Westchester Biotech Firm Just Received $300K to Develop a Novel Coronavirus Treatment

June 17, 2021

BioIncHarrison-based biotech firm Sapience Therapeutics, Inc. recently announced it received a Small Business Innovative Research (SBIR) Phase I grant, bestowed by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)

BioInc@NYMC news: Barry Kappel, Ph.D., M.B.A., president, chief executive officer and director of Sapience Therapeutics, a BioInc@NYMC client

Source: Westchester Magazine